Norway· NO-ID_08C892D3-919B-4C44-84BB-F13E759F666B

Ery-Max

A erythromycin product containing erythromycin, registered in Norway by Viatris AS. The same ATC class is registered in 13 of our 19 countries.

ATC J01FA01

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedEry-MaxATCJ01FA01REGISTER NO.NO-ID_08C892D3-919B-4…PACKS LISTED2CHECKEDSeptember 25, 2026

Where it is registered

Erythromycin is registered in 13 of 19 countries.

Countries holding a registration under ATC J01FA01 (erythromycin), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 6 of them publish a price we can compare per daily dose

Erythromycin · ATC J01FA01

13 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Erythromycin
Manufacturer
Viatris AS
Country
Norway (NO)
ATC code
J01FA01
ATC class
Erythromycin
Defined daily dose
1 g, O
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 2

1 priced
  • no_merkevare_id
    ID_08C892D3-919B-4C44-84BB-F13E759F666B
  • no_varenummer
    129825
    20
    NOK 505.5

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1011 interactions on record for erythromycin.

Graded by severity as the source publishes them — 216 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Erythromycin · interactions on record

1011 records

  • 216 severe
  • 424 moderate
  • 70 minor
  • 227 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • NaloxegolA06AH03severe

74 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Erythromycin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All erythromycin products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

  • Belgium · Erycine, Erythrocine
  • Cyprus · Ermyced, Ermycin
  • Czechia · Aknemycin
  • Germany · Aknemycin, Erythromycin Panpharma
  • Denmark · Abboticin, Erythromycin Panpharma
  • Spain · Eritromicina Panpharma, Oftalmolosa Cusí Eritromicina
  • Finland · Abboticin, Abboticin Novum
  • France · Ery, Ery Nourrissons
  • United Kingdom (Northern Ireland) · Erythrocin 250, Erythrocin 500
  • Greece · Acne Hermal, Dankit
  • Croatia · Eritromicin Belupo
  • Hungary · Aknemycin
  • Ireland · Erythrocin
  • Italy · Eritromicina Idi
  • Lithuania · Erythromycin Tc
  • Luxembourg · Aknemycin, Ery
  • Latvia · Erythromycin Tzf
  • Netherlands · Erythrocine, Erythrocine Es
  • Poland · Aknemycin, Cusi
  • Portugal · Akne-Mycin, Clinac
  • Romania · Eritromicină Atb
  • Sweden · Abboticin, Abboticin Novum
  • Slovakia · Aknemycin, Aknemycin 2000

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fe72b1a9-110a-4b94-8736-e98f8f6f7736
GET /v1/drugs/fe72b1a9-110a-4b94-8736-e98f8f6f7736?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Granulat til mikstur, suspensjon i dosepose",
  "source": "fest",
  "status": "A",
  "atc_name": "Erytromycin",
  "merkevare_id": "ID_08C892D3-919B-4C44-84BB-F13E759F666B",
  "name_form_strength": "Ery-Max granulat til mikst, susp 200 mg",
  "prescription_group": "C"
}

See everything about erythromycin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.